Vital Signs: A Pulse Check on the Healthcare Market

 

Political Economy Update – Markets, Policy and Deal Activity

Vital Signs is an overview of the current macroeconomic environment in the US healthcare markets, including policy and regulatory updates, the current administration's overhaul of US healthcare policies, and their impact on the life sciences ecosystem.

Our investment and corporate banking teams examine healthcare market activity and how these factors influence deal-making in both the US and Europe.

Given the current market dynamics, DNB//Back Bay will publish frequent updates to note changes in the regulatory and deal environment.

For the week ending June 20, we look at key regulatory and deal updates since Vital Signs was released in May 2025.

Please connect with us for any questions or comments.



Contributors

Greg Benning
Head of Investment Banking
Back Bay Life Science Advisors

Jonathan Gertler
Chief Executive Officer
Back Bay Life Science Advisors

Vasilios Kofitsas
Managing Director
Investment Banking
Back Bay Life Science Advisors

James Cirenza
Managing Director
Equity Capital Markets
DNB Markets, Inc.


Anne Grabe
Global Head of Healthcare
DNB Corporate Banking 

Dan Hochstadt
Managing Director
Head of IBD Americas
DNB Markets, Inc.

Crystal Hsu
Associate Director, Investment Banking
Back Bay Life Science Advisors

Andrew Davis
Senior Analyst, Investment Banking
Back Bay Life Science Advisors


Ethan Boultinghouse
Associate
DNB Markets, Inc

Krishna Kandala
Senior Associate
Back Bay Life Science Advisors

Nilay Neelaveni
Associate
DNB Markets, Inc.

 
 

Report Updates:

 

About the DNB // Back Bay Partnership:

The DNB//Back Bay Partnership was created to drive global healthcare growth and innovation. The DNB-Back Bay Partnership provides a full range of strategic advisory and financing capabilities along the full continuum of life science and healthcare company development. The DNB-Back Bay Partnership is a marketing term referring to a strategic agreement between DNB Markets, Inc. and Back Bay Life Science Advisors. More information about the DNB-Back Bay Partnership can be found here.

Securities products and services are offered in the U.S. through DNB Markets, Inc., a U.S. registered broker-dealer and a separately incorporated subsidiary of DNB Bank ASA. DNB Markets, Inc. is a member of the Financial Industry Regulatory Authority (“FINRA”) and the Securities Investor Protection Corporation (“SIPC”). Securities products and services are offered in the European Economic Area through DNB Carnegie.